secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001683168-24-008884
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharma raises ~$1.15M in registered direct offering & private placement
----------------------------------------------------------------------------

- Gross proceeds ~$1.15M; net proceeds ~$900K after fees and expenses.
- Sold 437,192 shares at $2.635/share in registered direct offering.
- Concurrent private placement: warrants to purchase 437,192 shares at $2.51, 5-year term.
- Proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acted as placement agent receiving 7.5% fee plus warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824008884/0001683168-24-008884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824008884/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer